121 related articles for article (PubMed ID: 25857330)
21. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha.
Chan DA; Sutphin PD; Yen SE; Giaccia AJ
Mol Cell Biol; 2005 Aug; 25(15):6415-26. PubMed ID: 16024780
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a robust enzymatic assay for inhibitors of 2-oxoglutarate-dependent hydroxylases.
Kanelakis KC; Palomino HL; Li L; Wu J; Yan W; Rosen MD; Rizzolio MC; Trivedi M; Morton MF; Yang Y; Venkatesan H; Rabinowitz MH; Shankley NP; Barrett TD
J Biomol Screen; 2009 Jul; 14(6):627-35. PubMed ID: 19498081
[TBL] [Abstract][Full Text] [Related]
23. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.
Berra E; Benizri E; Ginouvès A; Volmat V; Roux D; Pouysségur J
EMBO J; 2003 Aug; 22(16):4082-90. PubMed ID: 12912907
[TBL] [Abstract][Full Text] [Related]
24. Investigations on the role of a solvent tunnel in the α-ketoglutarate dependent oxygenase factor inhibiting HIF (FIH).
Chaplin VD; Valliere MA; Hangasky JA; Knapp MJ
J Inorg Biochem; 2018 Jan; 178():63-69. PubMed ID: 29078149
[TBL] [Abstract][Full Text] [Related]
25. The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability.
Barth S; Nesper J; Hasgall PA; Wirthner R; Nytko KJ; Edlich F; Katschinski DM; Stiehl DP; Wenger RH; Camenisch G
Mol Cell Biol; 2007 May; 27(10):3758-68. PubMed ID: 17353276
[TBL] [Abstract][Full Text] [Related]
26. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
Hewitson KS; Schofield CJ; Ratcliffe PJ
Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses.
Rabinowitz MH
J Med Chem; 2013 Dec; 56(23):9369-402. PubMed ID: 23977883
[TBL] [Abstract][Full Text] [Related]
29. Src activates HIF-1α not through direct phosphorylation of HIF-1α specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway.
Lee HY; Lee T; Lee N; Yang EG; Lee C; Lee J; Moon EY; Ha J; Park H
Carcinogenesis; 2011 May; 32(5):703-12. PubMed ID: 21335603
[TBL] [Abstract][Full Text] [Related]
30. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia.
Kunze R; Zhou W; Veltkamp R; Wielockx B; Breier G; Marti HH
Stroke; 2012 Oct; 43(10):2748-56. PubMed ID: 22933585
[TBL] [Abstract][Full Text] [Related]
31. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
Aprelikova O; Chandramouli GV; Wood M; Vasselli JR; Riss J; Maranchie JK; Linehan WM; Barrett JC
J Cell Biochem; 2004 Jun; 92(3):491-501. PubMed ID: 15156561
[TBL] [Abstract][Full Text] [Related]
32. The Oxygen Sensor PHD2 Controls Dendritic Spines and Synapses via Modification of Filamin A.
Segura I; Lange C; Knevels E; Moskalyuk A; Pulizzi R; Eelen G; Chaze T; Tudor C; Boulegue C; Holt M; Daelemans D; Matondo M; Ghesquière B; Giugliano M; Ruiz de Almodovar C; Dewerchin M; Carmeliet P
Cell Rep; 2016 Mar; 14(11):2653-67. PubMed ID: 26972007
[TBL] [Abstract][Full Text] [Related]
33. Selective inhibition of the hypoxia-inducible factor prolyl hydroxylase PHD3 by Zn(II).
Na YR; Woo DJ; Choo H; Chung HS; Yang EG
Chem Commun (Camb); 2015 Jul; 51(53):10730-3. PubMed ID: 26051901
[TBL] [Abstract][Full Text] [Related]
34. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
[TBL] [Abstract][Full Text] [Related]
35. Role of the intracellular localization of HIF-prolyl hydroxylases.
Yasumoto K; Kowata Y; Yoshida A; Torii S; Sogawa K
Biochim Biophys Acta; 2009 May; 1793(5):792-7. PubMed ID: 19339211
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
Chowdhury R; McDonough MA; Mecinović J; Loenarz C; Flashman E; Hewitson KS; Domene C; Schofield CJ
Structure; 2009 Jul; 17(7):981-9. PubMed ID: 19604478
[TBL] [Abstract][Full Text] [Related]
37. Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer.
Su Y; Loos M; Giese N; Metzen E; Büchler MW; Friess H; Kornberg A; Büchler P
Cancer; 2012 Feb; 118(4):960-72. PubMed ID: 21792862
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of prolyl-4-hydroxylase domain 2 inhibits tumor growth of human breast cancer MDA-MB-231 cells by affecting TGF-β1 processing.
Wottawa M; Leisering P; Ahlen Mv; Schnelle M; Vogel S; Malz C; Bordoli MR; Camenisch G; Hesse A; Napp J; Alves F; Kristiansen G; Farhat K; Katschinski DM
Int J Cancer; 2013 Jun; 132(12):2787-98. PubMed ID: 23225569
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of transforming growth factor β1/Smad3 signaling decreases hypoxia-inducible factor-1α protein stability by inducing prolyl hydroxylase 2 expression in human periodontal ligament cells.
Watanabe T; Yasue A; Tanaka E
J Periodontol; 2013 Sep; 84(9):1346-52. PubMed ID: 23088526
[TBL] [Abstract][Full Text] [Related]
40. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
Flashman E; Davies SL; Yeoh KK; Schofield CJ
Biochem J; 2010 Mar; 427(1):135-42. PubMed ID: 20055761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
